Código 3502 (Harmonized System 2012 by 4 digits)
2024: US$37.5M, Total Trade Exchange
2024: US$824k, International Sales
2024: US$36.7M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives was US$37.5M.
In 2024, the states with the most international sales in Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were Ciudad de México (US$684k).
The states with the most international purchases in 2024 were Ciudad de México (US$25.3M), Jalisco (US$9.16M), Nuevo León (US$721k), and Estado de México (US$429k).
In 2024, the main commercial destinations of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were United States (US$400k), Guatemala (US$142k), El Salvador (US$142k), and Israel (US$155).
The main commercial origins of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives in 2024 were United States (US$20.3M), Denmark (US$6.93M), Ireland (US$3.42M), Norway (US$1.78M), and Germany (US$1.46M).
In the global context, the main exporting countries of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives in 2022 were United States (US$799M), Germany (US$498M), and Netherlands (US$437M). In the same year, the main importing countries of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were Japan (US$495M), China (US$460M), and United Kingdom (US$246M).
US$37.5M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives in Mexico (including international purchases and sales) was US$37.5M.
The visualizations show the net balance of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
March, 2025: US$1.24M, International Purchases
In March 2025, international sales of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were US$0, while international purchases reached US$1.24M. The above results in a trade balance of -US$1.24M.
Ciudad de México: US$684k, State with the Most International Sales (2024)
United States: US$400k, Main commercial destination (2024)
In 2024, the states with the highest international sales in Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were Ciudad de México (US$684k).
In 2024, the countries with the most international purchases from Mexico were United States (US$400k), Guatemala (US$142k), El Salvador (US$142k), and Israel (US$155).
Ciudad de México: US$25.3M, State with the Most International Purchases (2024)
United States: US$20.3M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were Ciudad de México (US$25.3M), Jalisco (US$9.16M), Nuevo León (US$721k), and Estado de México (US$429k).
The countries with the most international sales to Mexico in 2024 were United States (US$20.3M), Denmark (US$6.93M), Ireland (US$3.42M), Norway (US$1.78M), and Germany (US$1.46M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were United States (US$799M), Germany (US$498M), and Netherlands (US$437M). In the same year, the main importing countries for Albumins (Including Concentrates of Whey Proteins with a Protein Content of Whey than 80% in Weight, Calculated on Dry Matter), Albuminates and other Albumin Derivatives were Japan (US$495M), China (US$460M), and United Kingdom (US$246M).